These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 8714365)

  • 21. Calcium antagonists for antihypertensive baseline therapy. First International Nitrendipine Symposium. Interlaken, April 13-14, 1984.
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S929-1113. PubMed ID: 6085378
    [No Abstract]   [Full Text] [Related]  

  • 22. Effects of valsartan and nifedipine coat-core on systemic arterial stiffness in hypertensive patients.
    Munakata M; Nagasaki A; Nunokawa T; Sakuma T; Kato H; Yoshinaga K; Toyota T
    Am J Hypertens; 2004 Nov; 17(11 Pt 1):1050-5. PubMed ID: 15533733
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The use of short-acting nifedipine in children with hypertension: another example of the need for comprehensive drug testing in children.
    Sinaiko AR; Daniels SR
    J Pediatr; 2001 Jul; 139(1):7-9. PubMed ID: 11445783
    [No Abstract]   [Full Text] [Related]  

  • 24. [Are newer antihypertensive agents better than the older ones? Results of trials (CAPPP, STOP-2, NORDIL, INSIGHT and ALLHAT) with newer antihypertensive agents].
    Hildebrandt PR; Tuxen CD; Kjeldsen SE; Lund-Johansen P; Hansson L
    Ugeskr Laeger; 2001 Dec; 164(1):18-21. PubMed ID: 11810791
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Large scale clinical trials of calcium channel blockers on the prevention of cardiovascular diseases].
    Shimamoto K
    Clin Calcium; 2005 Oct; 15(10):1609-14. PubMed ID: 16199905
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Calcium-channel blockers for hypertensive emergencies.
    Frishman WH
    J Clin Hypertens; 1986 Sep; 2(3 Suppl):55S-61S. PubMed ID: 3540227
    [No Abstract]   [Full Text] [Related]  

  • 27. Calcium channel blockers: an evidence-based review.
    Waters D
    Can J Cardiol; 1997 Aug; 13(8):757-66. PubMed ID: 9284842
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-acting nifedipine in the management of the hypertensive patient.
    Snider ME; Nuzum DS; Veverka A
    Vasc Health Risk Manag; 2008; 4(6):1249-57. PubMed ID: 19337538
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Antihypertensive therapy. Can a calcium antagonist stop arteriosclerosis?].
    MMW Fortschr Med; 2001 May; 143(22):53. PubMed ID: 11460409
    [No Abstract]   [Full Text] [Related]  

  • 30. Correction of hypertensive cardiac remodelling: comparison of different antihypertensive therapies.
    Almazov VA; Shlyakhto EV; Konrady AO; Macsimova TA; Zaharov DV; Rudomanov OG
    Med Sci Monit; 2000; 6(2):309-13. PubMed ID: 11208328
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The effects of antihypertensive drugs on lipid metabolism. Part I. Diuretics, beta-blockers, calcium antagonists].
    Martynov AI; Ostroumova OD; Mamaev VI; Rybkina TE; Kuznetsov VI; Tikhonova LIa; Smirnova MV
    Klin Med (Mosk); 2001; 79(8):8-12. PubMed ID: 11588795
    [No Abstract]   [Full Text] [Related]  

  • 32. Meta-analysis of the long-term effect of nifedipine for pulmonary hypertension.
    Malik AS; Warshafsky S; Lehrman S
    Arch Intern Med; 1997 Mar; 157(6):621-5. PubMed ID: 9080916
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Angiotensin converting enzyme inhibition and dihydropyridine calcium channel blockade in the treatment of left ventricular hypertrophy in arterial hypertension.
    Palmieri V; Devereux RB
    Minerva Cardioangiol; 2002 Jun; 50(3):169-74. PubMed ID: 12107398
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Calcium antagonists: first choice antihypertensive drugs].
    Zidek W
    Med Klin (Munich); 2005 Jun; 100(6):347-52; quiz 353-4. PubMed ID: 15968487
    [No Abstract]   [Full Text] [Related]  

  • 35. Should calcium channel blockers be used as first-line antihypertensive therapy?
    Reust CE
    J Fam Pract; 2001 Mar; 50(3):258. PubMed ID: 11252219
    [No Abstract]   [Full Text] [Related]  

  • 36. [Calcium antagonists in cardiovascular disease. Clinical evidence from morbidity and mortality trials].
    Oparil S; Bakir SE
    Drugs; 2000; 59 Spec No 2():25-37. PubMed ID: 11002856
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antihypertensive effect of amlodipine compared with nifedipine retard in patients with mild and moderate essential hypertension.
    Kalina Z; Okopień B; Madej A; Tokarz D; Maślankiewicz A; Szwed Z; Gross-Furek V; Herman ZS
    Boll Chim Farm; 1998; 137(7):281-5. PubMed ID: 9795483
    [TBL] [Abstract][Full Text] [Related]  

  • 38. INSIGHT and NORDIL. International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment. Nordic Diltiazem Study.
    García-López FJ; de Alvaro F
    Lancet; 2000 Dec; 356(9245):1926; author reply 1928-9. PubMed ID: 11130402
    [No Abstract]   [Full Text] [Related]  

  • 39. [The effect of amlodipine, nifedipine and perindopril on insulin sensitivity and blood lipid of patients with essential hypertension].
    Lin J; Chen D; Wu K
    Zhonghua Yi Xue Za Zhi; 1998 Mar; 78(3):200-2. PubMed ID: 10923530
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Control of edema in hypertensive subjects treated with calcium antagonist (nifedipine) or angiotensin-converting enzyme inhibitors with Pycnogenol.
    Belcaro G; Cesarone MR; Ricci A; Cornelli U; Rodhewald P; Ledda A; Di Renzo A; Stuard S; Cacchio M; Vinciguerra G; Gizzi G; Pellegrini L; Dugall M; Fano F
    Clin Appl Thromb Hemost; 2006 Oct; 12(4):440-4. PubMed ID: 17000888
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.